SEATTLE – Researchers reported here at the Association for Research in Vision and Ophthalmology meeting that a thicker retinal nerve fiber layer was associated with better performance on the mini mental state examination and reaction time.Eneh Jones-Odeh, of King’s College, London, said she and her colleagues evaluated twins “to determine the relationship between RNFL and how well people perform in different cognitive tests.”
SEATTLE – Researchers reported here at the Association for Research in Vision and Ophthalmology meeting that a thicker retinal nerve fiber layer was associated with better performance on the mini mental state examination and reaction time.Eneh Jones-Odeh, of King’s College, London, said she and her colleagues evaluated twins “to determine the relationship between RNFL and how well people perform in different cognitive tests.”
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
SEATTLE – A survey of contact lens wearers showed that the majority said they receive information on contact lens care from their doctors; however, compliance is still an issue.“Despite Internet access, people are more likely to get information from doctors,” Margaret Wang told Primary Care Optometry News here at the Association for Research for Vision and Ophthalmology meeting. “But we found that people don’t necessarily listen to their doctors.”
SEATTLE – A survey of contact lens wearers showed that the majority said they receive information on contact lens care from their doctors; however, compliance is still an issue.“Despite Internet access, people are more likely to get information from doctors,” Margaret Wang told Primary Care Optometry News here at the Association for Research for Vision and Ophthalmology meeting. “But we found that people don’t necessarily listen to their doctors.”
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report f…